1. Kaur R, Gulati M, Singh SK. Role of synbiotics in polysaccharide assisted colon targeted microspheres of mesalamine for the treatment of ulcerative colitis. Int J Biol Macromol. 2016;11:1–42.
2. Izzo R, Bevivino G, Monteleone G, Izzo R, Bevivino G, Monteleone G. Tofacitinib for the treatment of ulcerative colitis. Expert Opin Investig Drugs. 2016:1–21.
3. Centre N. Clinical guideline. Ulcerative colitis : Management in adults, children and young people. In: Clinical guideline: methods, evidence and recommendations. London: National institute for health and care excellence (NICE); 2013. p. 1–297.
4. César B, Lyra AC, Rocha R, Santana GO. Epidemiology, demographic characteristics and prognostic predictors of ulcerative colitis. World J Gastroenterol. 2014;20(28):9458–67.
5. Baumgart DC. In: Colitis UD c. B, editor. Crohn’s disease and ulcerative colitis; from epidemiology and immunobiology to a rational diagnostic and therapeutic approach. Berlin: Springer Netherlands; 2012. p. 1–741.